For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.

Meet the anti-antitrust coalition.

With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M pharmaceutical industry, 31 of its biggest players -- including Merck, Amgen, Abbvie, and Gilead -- formed an alliance to fight the reforms. Their chief enemy? Khaaaaaaaaaaan!

Continue reading

Source Fool.com